Interferon regulatory factor 1 (IRF-1) and IRF-8, also known as interferon consensus sequence binding protein (ICSBP), are important regulators of macrophage differentiation and function. These factors exert their activities through the formation of heterocomplexes. As such, they are coactivators of various interferon-inducible genes in macrophages.
Introduction

Interferon (IFN) regulatory factor-8 (IRF-8), also known as interferon consensus sequence binding protein (ICSBP), and
Abbreviations: CML, chronic myelogenous leukemia; CXCL16, Cxc chemokine ligand 16; ICSBP, interferon consensus sequence binding protein; IFN, interferon; IL-17R, interleukin-17 receptor; IRF, IFN regulatory factor; KO, knockout; LIF, leukemia inhibitory factor; MAP4K4, mitogen activated protein kinase 4; MiHC, minor histocompatibility complex 28 (H28); MMP9, matrix metalloproteinase 9; MYC, myelocytomatosis oncogene; PCDH7, protocadherin 7; PML, promyelocytic leukemia; WT, wild type IRF-1 are members of the IRF family of transcription factors, which include nine cellular members (Mamane et al., 1999) . In general, these factors are important immunomodulators and are essential components of the IFN signaling cascade. Using in vitro assays, these two transcription factors were identified in association on the promoter region of numerous macrophage essential genes (Marecki and Fenton, 2000; Xiong et al., 2003) . IRF-8 is a key element for the differentiation of myeloid progenitor cells towards macrophages and for mature macrophage activity. Accordingly, IRF-8 −/− mice exhibit clinical manifestation that resembles the human chronic myelogenous leukemia (CML). Comparable to CML patients, these mice experience a rapid and systemic expansion of granulocytes that eventually results in a fatal blast crisis (Holtschke et al., 1996) . Consistent with this, lack of IRF-8 was reported in human myeloid leukemias, implicating its pivotal role as a tumor suppressor gene (Schmidt et al., 1998) . Thus, IRF-8 drives bipotential myeloid progenitor cells towards mature macrophages while inhibiting the differentiation pathway towards granulocytes (Tamura et al., 2000) . In addition, it was shown that IRF-8 is an essential factor for proper functioning of mature macrophages. For example, IRF-8 null mice fail to mount Th1-mediated immune response, since they fail to produce the IL-12 p40 subunit (Wang et al., 2000) . Similarly, IRF-1 −/− are also devoid of Th1 responses due to deficiency of the same IL-12 subunit (Taki et al., 1997; Lohoff et al., 1997) .
Further, clinical studies have assigned important role for IRF-1 in the onset of myelodysplastic syndromes, which are clonal myeloid disorders (Willman et al., 1993) . These studies indicate that IRF-1, like IRF-8, is a tumor suppressor gene with essential functions in the maturation of myeloid cells to macrophages. Unlike other IRF members, IRF-8 is capable of binding to its target DNA sequence only following association with either IRF-1 and IRF-2 or non-IRF transcription factors, such as PU.1, an essential factor for hematopoiesis (Sharf et al., 1997; Wang et al., 2000; Dahl and Simon, 2003) . The domain essential for these protein-protein associations, termed IRF association domain (IAD), is conserved among all other IRF members excluding IRF-1 and IRF-2. The association modules of IRF-1 and IRF-2 with IRF-8 were identified as PEST domains, enriched with proline, glutamic acid, serine, and threonine, originally shown in PU.1 . The specific partner that interacts with IRF-8 dictates not only the DNA binding site but also the transcriptional activity e.g. activation or repression. The stoichiometry between the interacting partners was not determined and it is possible that several PEST domains interact with an IAD, as observed on promoters of several macrophage specific genes, such as IL-12, IL-1␤, and ISG15 Marecki et al., 2001 ).
As mentioned above, IRF-1 is one of the partners associated with IRF-8. Together, they play critical role in the regulation of several pro-inflammatory genes that function during macrophage activation; These two factors synergistically regulate the transcription of iNOS (Xiong et al., 2003) , the two components of the phagocyte respiratory burst oxidase: p67 and gp91 (Eklund and Kakar, 1999) , the transcription of IL-12 (Masumi et al., 2002) , IL-18 (Kim et al., 1999) , IL-1␤ (Marecki et al., 2001) , and ISG15 . Taken together, IRF-8 and IRF-1 are essential components of macrophage functioning and innate immune response.
To get better insight into the role of these transcription factors in the onset of the innate immune response and to identify their regulatory network in macrophages, we performed DNA microarray analysis. We have used mRNA retrieved from macrophages extracted from IRF-8 knockout (KO) mice, IRF-1 KO mice, and C57BL/6J, the counterpart wild type (WT) strain. Changes in the expression profiles were analyzed before and after 4 h of exposure to both IFN-␥ and LPS. The levels of mRNA transcripts from treated and untreated macrophages were compiled and compared. The expression of 265 genes was significantly altered (fold of change ≥2.0, p < 0.001) in WT mice while no changes were observed in the transcripts of these genes in both KO mice. Thus, our results suggest that both IRF-1 and IRF-8 are involved in the transcriptional regulation of these differentially expressed genes. Among these putative target genes, numerous are involved in macrophage activity during inflammation pointing to the pivotal regulatory role of both IRF-1 and IRF-8 in the inflammatory process.
Materials and methods
Animals
The mouse strains; C57BL/6J (Harlan Biotech, Israel), IRF-1 deficient (kindly obtained from Dr. Rubinstein, The Weizmann Institute, Israel, originally from The Jackson Laboratory), and IRF-8 deficient (Holtschke et al., 1996) , were maintained in microisolator cages in a viral pathogen-free facility.
Isolation of peritoneal macrophages
Four days prior to experiment, mice were injected i.p. with 3 ml 3% sterile thioglycolate medium. Mice were sacrificed by CO 2 inhalation, 10 ml sterile PBS was injected to the peritoneal cavity, peritoneal lavage enriched in macrophages were extracted. Peritoneal macrophages were washed in 15 ml of pre-warmed RPMI 1640 supplemented with 2% FCS, 2 mM glutamine, 30 mM HEPES, 0.4% sodium bicarbonate, and penicillin and streptomycin (100 IU/ml and 100 g/ml, respectively). ∼2.5 × 10 6 cells were plated in tissue culture Petri dishes (100 mm) at 37 • C and 6% CO 2 . Four hours later, non-adherent cells were removed by two successive washes and 24 h later, adherent cells were either not treated or treated for 4 h with 100 U/ml IFN-␥ (CytoLab, Rehovot, Israel) and 50 ng/ml LPS (Sigma). All animal work conformed to the guidelines of the animal care and use committee of Technion-Israel Institute of Technology.
Cell lines
Murine bone marrow derived RAW264.7 macrophage cell line was obtained from ATCC (Manassas, VA). CL-2 macrophage cells, established from IRF-8 KO mice, were previously reported (Wang et al., 2000) . Cells were maintained in RPMI 1640, supplemented with 40 M ␤-mercaptoethanol, 10% FCS and antibiotics. Five nanograms per millilitre M-CSF and CSF (R&D systems, Minneapolis, MN) were added to the growth medium of CL2 cells. Treatment with IFN-␥ and LPS was performed as described for peritoneal macrophages.
Plasmids
Mammalian expression vectors encoding for IRF-8, IRF-1, and PU.1 were all described previously (Alter-Koltunoff et al., 2003) . The reporter construct pGL3-MMP9, containing the −634 to +30 bp of the MMP9 promoter, driving the expression of the luciferase gene, was kindly obtained from Dr. Douglas D. Boyd (The University of Texas MD Anderson Cancer Center, Houston, TX). The pGL3-PML containing the 1.44 kb promoter region conjugated to luciferase was a kind gift from Dr. Hugues de Thé (Hopital St. Louis, Paris, France). Genomic DNA fragment corresponding to the promoter region of pCDH7 (from position-1, upstream to the translation initiation site, up to position-1000) was PCR amplified (5 primer CCGCTAGC-CCTCACTTCAGCTCTTAC; 3 primer GAGATCTTGTTG-GAGCAGTGGGATC) and cloned between the SacI and XhoI restriction sites of the basic reporter plasmid pGL3 (Promega).
RNA extraction, sample preparation, hybridization, and array processing
Plates were washed once with 10 ml of ice cold PBS, then lysed with 1 ml/plate of Tri-Reagent (Sigma) and RNA was prepared according to the manufacturer instructions.
Total RNA from each sample was used to prepare biotinylated target RNA, with minor modifications from the manufacturer's recommendations. Briefly, 10 g of total RNA was used to generate first-strand cDNA by using a T7-linked oligo (dT) primer. After second-strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP (Enzo Diagnostics), resulting in approximately 100-fold amplification of RNA, which was then processed as per manufacturer's recommendation using an Affymetrix GeneChip Instrument System. Briefly, spike controls were added to 10 g fragmented cRNA before overnight hybridization. Arrays were then washed and stained with streptavidin-phycoerythrin, before being scanned on an Affymetrix GeneChip scanner.
Quality and amount of starting RNA were confirmed using an agarose gel. Following scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches. 3 /5 ratios for glyceraldehyde-3 -phosphate dehydrogenase (GAPDH) and ␤-actin were confirmed to be within acceptable limits range from QC report here, and BioB spike controls were found to be present on 100%, with BioC, BioD and CreX also present in increasing intensity. When scaled to a target intensity of 150 (using Affymetrix MAS 5.0 array analysis software), scaling factors for all arrays were within acceptable limits as were background, Q values and mean intensities.
All experiments were performed using Affymetrix Mouse 430A 2.0 oligonucleotide arrays, as described at http://www. affymetrix.Com/products/arrays/specific/mgu74.affx.
Genes were filtered using Mas 5 algorithm results. A list of 14,025 probe sets, "valid genes", representing probe sets with signals higher than 20 and detected as "present" in at least one sample was obtained.
DNA transfections and reporter gene analyses
RAW 264.7 and CL-2 cells were diluted to 10 6 cells/ml 16-24 h prior to transfection. At the time of transfection, cells were washed twice in phosphate buffered saline (PBS) and suspended at 4 × 10 7 cells/ml in RPMI medium lacking fetal calf serum and antibiotics. 0.25 ml of the cell suspension was placed into 0.4 cm electroporation cuvette (Bio-Rad, Richmond, CA, USA) with up to 30 g of plasmids DNA suspended in no more than 20 l of distilled water, including 8 g of the various reporter gene constructs and 1 g of IRF-8 and/or IRF-1 expression plasmids (as indicated in the text). Cells and plasmids DNA were incubated for 5 min at room temperature prior to electroporation at 960 F and 300 V for RAW264.7 cells and 250 V for CL-2 (Bio-Rad gene pulser). Following the electric shock, cells were left at room temperature for additional 15 min and then diluted into 10 ml of RPMI containing 10% FCS. Twentyfour hours following electroporation, cells were harvested, lysed using the lysis buffer of the Dual Luciferase assay kit (Promega), and luciferase activities were determined according to the manufacturer's instructions using a TD-20/20 luminometer (Turner Design, Promega). Reporter gene activities were normalized for protein concentration and transfection efficiencies as described (Subramaniam et al., 1999b) . Each set of transfection experiments was repeated at least three times generating similar results.
Quantitative RT-PCR analysis
A quantitative real-time-PCR analysis of mRNA expression was performed to confirm the differential expression of the selected genes. Hundred nanograms of total RNA from each sample was reverse-transcribed to cDNA using Reverse-iT TM 1st strand synthesis kit (ABgene, Surrey, UK) according to manufacturer's instructions. cDNA was amplified with two primers for each gene (Table 1) using ABsolute SYBER Green ROX Mix (ABgene, Surrey, UK) and Rotor-Gene 3000 TM Real-Time thermal cycler (Corbett Research, Australia) according to the manufacturer's instructions. Briefly, 4 l of cDNA template (diluted 1:10) was mixed with 5 pmol of each primer (Sigma), 12.5 l ABsolute reaction mix and H 2 O to reach 25 l per reaction. The amplification conditions for all reactions were 1× 95 • C for 15 min followed by 40× 95 • C for 10 s, 60 • C for 20 s, 72 • C for 15 s. Melting reaction (72-99 • C) for 5 s/1 • C verified that the reactions contained a unique product. Transcript levels were normalized against the expression levels of GAPDH. Standard curves were constructed for each run by using serial dilutions of the corresponding cDNA from RAW 264.7 cells. Each standard and sample was measured in triplicates. Quantitative results of real-time PCR were assessed by determining the relative calculated concentration (Copies) value. A calibration curve was derived by plotting the calculated concentration values obtained for each dilution. The calibration curves showed a correlation coefficient (R 2 ) between 0.98 and 1.01. The estimated amount of transcripts was normalized to GAPDH mRNA expression to compensate for variations in quantity or quality of starting mRNA and for differences in reverse transcriptase efficiency. The gene of interest/GAPDH ratio is expressed in percentages.
Bioinformatics analysis of promoter regions
Analysis of the promoter sequences was carried out with GEMS Launcher (Genomatix Software GmbH, Munich, Germany) using the FrameWorker tool which is based on the algorithms described Quandt et al., 1995 Quandt et al., , 1996 . TCCAAAGTACCCTGCGGTATC  139  H28  TTCAACTCAGTGGAAGTCTGCT  GGAGTGTTTCCCCGCTTTTTC  134  IL-17R  AGTGTTTCCTCTACCCAGCAC  GAAAACCGCCACCGCTTATTAC  194  LIF  GCTATGTGCGCCTAACATGAC  CGCTCAGGTATGCGACCAT  101  MAP4K4  TCTGGCTTGTTATGGAGTTT  CTTTGAGAGTGTTCCCTTTG  78  MMP9  CGATTTGAAGTCTCAGAAGG  TACTGGAAGATGTCGTGTGA  96  MYC  TCTCCATCCTATGTTGCGGTC  TCCAAGTAACTCGGTCATCATCT  114  PCDH7  GTTAATGCCAAAGACAAAGG  TTGCATAAACTTAGGGTCGT  99  PML  CAGGCCCTAGAGCTGTCTAAG  ATACACTGGTACAGGGTGTGC  78  SOCS7  TCCTCCAAGAAGAAGCCTCA  GGAGGTAGGGGGAAAGACTG  108  GAPDH  AGGTCGGTGTGAACGGATTTG  TGTAGACCATGTAGTTGAGGTCA  123 a Primers were designed using Primer3 software: http://www-genome.wi.mit.edu/cgi-bin/primer/primer3.
Results
Stimulation of peritoneal macrophage with IFN-γ and LPS leads to differential expression of genes involved in various aspects of macrophage activity
To look for changes in peritoneal macrophages expression profile following stimulation, mice were injected intraperitoneally with thioglycolate and cells were extracted by peritoneal lavage 4 days later. The isolated macrophages were either treated or not treated with IFN-␥ and LPS to mimic bacterial infection. Four hours later, total RNA was extracted and utilized for DNA microarray analysis. We focused on early response transcripts whose expression level changed significantly following stimulation in macrophages from WT mice.
Twelve thousand seven hundred and thirteen probe sets indicated valid signals from which data could be analyzed. Among these, the expression level of 1009 genes was significantly changed (up or down) in macrophages from WT mice treated with IFN-␥ and LPS (Fig. 1) . This list includes numerous transcripts that have been reported to be altered following macrophage activation, such as IL-1␤, IL-6, iNOS, TNF recep- tor 1, GBP and more (for review see Ricciardi-Castagnoli and Granucci, 2002) . Altogether, these data demonstrate the validity of the results obtained by the array analysis.
Microarray analysis revealed a group of genes regulated by both IRF-1 and IRF-8
Our main goal in this study was to identify genes that are potentially regulated by both IRF-1 and IRF-8 using DNA microarray with mRNA extracted from macrophages of the corresponding KO mice. We focused on transcripts whose expression level changed significantly following stimulation in WT macrophages, but were unchanged in macrophages from both IRF KOs. Out of the 1009 genes that were either up-or downregulated in activated macrophages extracted from WT mice, 387 and 360 genes did not exhibit any significant change in the IRF-1 and IRF-8 KO mice, respectively (Fig. 1) . Among these unaffected genes in the KO mice, 265 transcripts did not exhibit any change in expression pattern in both KO strains following macrophage activation. Thus, our results suggest that both IRF-1 and IRF-8 are essential transcriptional regulators of these 265 genes in activated macrophages.
Quantitative RT-PCR analysis confirms the role of both IRF-1 and IRF-8 in the regulation of genes involved in innate immune response
Many genes essential for innate immune response were among those that their expression was not changed in macrophages from KO mice compared to macrophages from the WT mice. This group included 10 genes of interest; Cxc chemokine ligand 16 (CXCL16), minor histocompatibility complex (MiHC) 28 (H28), interleukin-17 receptor (IL-17R), leukemia inhibitory factor (LIF), mitogen activated protein kinase 4 (MAP4K4), matrix metalloproteinase 9 (MMP9), myelocytomatosis oncogene (MYC), protocadherin 7 (PCDH7), promyelocytic leukemia (PML), and suppressor of cytokine signaling 7 (SOCS7). To further validate the microarray results observed for these genes, quantitative RT-PCR studies were performed (Fig. 2) . As can be seen in Fig. 2 , the expression levels of CXCL16, H28, IL-17R, LIF, MAP4K4, MMP9, MYC, PCDH7, PML, and SOCS7 were significantly increased in macrophages extracted form WT mice (black columns) following activation for 4 h with IFN-␥ and LPS. However, no changes in the expression of these genes were observed in cells extracted from IRF-8, as well as from IRF-1 null mice (white and gray columns, respectively). The only exceptional gene was LIF whose expression level in IRF-1 −/− was similar to that of WT. The expression level of IL-6 is not dependent on IRF-1 and IRF-8 and therefore served as a control.
Promoter analysis reveals the participation of both IRF-1 and IRF-8 in the activation of target promoters
In silico analysis of the putative promoter region (∼1 kb upstream to the predicted transcription start site) revealed that all 10 genes harbor common DNA binding motifs like Interferon simulated response elements (ISREs) to which IRFs can bind, as well as sites for the putative binding of NFB, PU.1, AP-1, SP1 and E-box binding proteins. This data implies that their signalosome context might share similar characteristics.
To verify the ability of some of the promoters of the tested genes to respond to IRF-1 and IRF-8, reporter gene assays were performed. The macrophage cell line RAW264.7 was transfected with the reporter constructs driven by either the MMP9, or the PCDH7 or the PML promoter. Cells were cotransfected with expression constructs for IRF-1 IRF-8 or both, and either not treated or treated with IFN-␥ and LPS for 24 h. The level of the luciferase reporter gene expression was determined. As seen in Fig. 3A (black columns) , treatment of transfected cells with IFN-␥ and LPS led to the activation of the MMP9 reporter construct. Further, cotransfection of IRF-8 expression construct alone elicited stronger activation of this reporter than IRF-1 alone. Cotransfection of both expression constructs for IRF-1 and IRF-8 led to an additive activation of the reporter construct. This further supports the role of both factors as immediate regulators of MMP9 in macrophages. The same types of experiments were performed with the reporter constructs harboring the promoters of PCDH7 (Fig. 3B) and PML (Fig. 3C) . In principal, similar results were observed. Both promoters were activated in the transfected cells by IFN-␥ and LPS and by each of the trans- fected factors or combination. The same type of experiments was also performed in CL-2 cells, a macrophage cell line originated from IRF-8 −/− mice (Fig. 3, white columns) . In these cells, stimulation with IFN-␥ and LPS was not sufficient to activate all three reporter constructs, indicating the pivotal role of IRF-8 in the regulated expression of these three tested promoters. Reintroduction of IRF-8 to these cells was sufficient to activate all three promoters, and maximal activation was observed when both IRF-8 and IRF-1 were cotransfected. However, transfection of IRF-1 alone was not sufficient to activate both MMP-9 and PCDH7 promoters, indicating that IRF-8 and IRF-1 are essential co-regulators. Taken together, these results point to the key role of IRF-8 and IRF-1 in the expression of MMP9, PCDH7 and PML in activated macrophages.
Discussion
Both IRF-1 and IRF-8 have important roles in the maturation and the function of macrophages. Accordingly, mice with null mutations for these two genes exhibit severe defects in both innate and adaptive immunity. These mice manifest abnormalities in the early phases of myelopoiesis, are unable to mount Th1 mediated immune response, and are sensitive to various pathogens (Tamura and Ozato, 2002; Taniguchi et al., 1901; Testa et al., 1995) . These two IRF members associate through characterized domains to create transcriptional heterocomplexes that bind and regulate various promoters of macrophage essential genes Marecki et al., 2001; Tamura et al., 2000) . To search for yet unidentified target genes for these two transcription factors in macrophages, DNA microarray analysis was employed. We compared the expression profile of peritoneal macrophages from WT mice following stimulation with IFN-␥ and LPS to that of treated macrophages from IRF-1 and IRF-8 KO mice. As shown in Fig. 1 , numerous genes (1009) exhibited significant changes in their expression pattern in WT macrophages in accordance to previously published data (Ricciardi-Castagnoli and Granucci, 2002) . To our surprise, the expression of about a third of these genes was significantly uninduced in IRF-1 (387) and IRF-8 (360) defective mice. This data points to the pivotal role of each IRF member in the regulation of gene expression in activated macrophages. The list of genes is not restricted only to those essential for macrophage function but also to genes with more general activities.
Among the genes whose expression was changed in WT following activation, we looked for those whose expression was not changed both in IRF-1 −/− and IRF-8 −/− macrophages. We assumed that the skewed expression observed in the KO mice after activation, may result from the absence of the respective transcription factors, implying that these non-induced genes are potentially regulated by both IRF-1 and IRF-8. The expression level of 265 transcripts was changed in WT macrophages and not in both KOs following activation. We chose to further validate the microarray results for 10 genes that may take part in the innate immune response. In silico analysis of the putative promoters of these 10 genes (1 kb upstream to the predicted transcription start site) revealed common putative DNA motifs for the binding of IRFs, PU.1, NFkB and AP1. This suggests that these genes might respond to similar signaling cues in macrophages and therefore their enhanceosomes are organized in a similar architecture. The promoters of three of these genes were further analyzed by reporter gene assays demonstrating the role of both IRF-8 and IRF-1 in their coordinated regulation in activated macrophages.
As mentioned, we have looked at only 10 of the many putative genes that are regulated by both IRF-1 and IRF-8 in activated macrophages. These genes are involved in key processes taking part in the onset of innate response. Based on our data we suggest that in addition to the already described activities of these two transcription factors in mature macrophages, they also play significant roles in adhesion, chemotaxis, ECM degradation, antigen presentation, cytokine signaling, and apoptosis. The partial putative regulatory network for IRF-1 and IRF-8 in activated macrophages through the regulation of PCDH7, H28, LIF, PML, CXCL16, IL-17R, MYC, MMP9, MAP4K4, SOCS7, is illustrated in Fig. 4 .
Cells congregation and cell-cell interactions of macrophages is a fundamental event in the inflammatory cascade following infection. To get an efficient response, macrophages enhance their mobility and aggregate in the infected site (Peters et al., 2000) . This accumulation of macrophages in the infected site may be accomplished through the expression of cell surface adhesion molecules, such as PCDH7, which belongs to the protocadherins family of cadherins. These proteins play an important role in cell-cell adhesion of specific neurons in the central nervous system (Yoshida, 2003) . Of the reported PCDHs, relatively little is known about the function of PCDH7. However, its putative involvement in the inflammatory process through IKK/NFkB signaling was reported (Li et al., 2002) . We suggest that PCDH7 adhesion molecule, regulated by both IRF-1 and Two other important processes taking place during innate immune response; chemotaxis and the recruitment of immune cells to the infected site. Being involved in the initial steps in the onset of inflammation upon infection, macrophages signal to other professional immune cells. Through chemotaxis and antigen presentation, neutrophils, T cells, and NK cells are recruited to the inflamed site. We suggest that IRF-1 and IRF-8 are important factors in this event through the regulation of CXCL16, IL-17R, and MiHC H28. CXCL16 is a chemokine expressed by macrophages, dendritic cells (DCs), and endothelial cells (Matloubian et al., 2000; Shimaoka et al., 2003; Wilbanks et al., 2001) . When expressed at the cell surface, CXCL16 functions as a scavenger receptor, binding and internalizing oxidized low-density lipoprotein and bacteria. As a soluble form, CXCL16 is a chemoattractant for activated CD4 + and CD8 + T cells through binding its receptor, CXCR6. CXCL16 is synthesized as an intracellular precursor that is rapidly transported to the cell surface where it undergoes metalloproteinase-dependent (ADAM10) cleavage, causing the release of a soluble chemoattractant (Matloubian et al., 2000; Wilbanks et al., 2001) . IL-17 is a cytokine secreted exclusively by activated T cells. Its receptor, IL-17R, is expressed in all tissues examined to date (Moseley et al., 2003) and signals through extracellular signal-regulated protein kinase (ERK), c-jun N-terminal kinase (JNK), and p38 MAP kinase pathways resulting in the induction of pro-inflammatory cytokines (Shalom-Barak et al., 1998; Martel-Pelletier et al., 1999; Subramaniam et al., 1999a,b) . H28 belongs to the MiHC (H locus) and is being presented by antigen presenting cells following induction with inflammatory cytokines (Malarkannan et al., 2000) .
The accumulation of macrophages at the infected site is an important part of innate immunity and the inflammatory response. The tissue destruction that accompanies infection is facilitated by the matrix metalloproteinases (MMPs). This family of proteinases is expressed in macrophages in response to inflammatory stimuli, such as LPS or IFN-␥ and subsequently degrades the ECM. MMP9, also known as Gelatinase B, can degrade extracellular matrix components such as collagens and elastins. Like most MMPs, it is made as a proenzyme that requires proteolysis that is the limiting step in the degradation of extracellular matrix (Min et al., 2002; Pendas et al., 1997) . Interestingly, Koenders et al., reported a critical role of IL-17R signaling in the expression of pro-inflammatory and catabolic mediators, such as IL-1 and MMP-9 during chronic T cell-mediated synovitis, which is macrophage-driven joint inflammation (Koenders et al., 2005) . Like other immune cells, macrophages are produced in large amounts in response to a stimulus and eventually undergo apoptosis (Xaus et al., 2001 ). These two processes may be achieved by the simultaneous expression of both proliferative and pro-apoptotic antagonistic genes. Therefore, it is not surprising to find both c-Myc and PML upregulated in activated macrophages. c-Myc regulates diverse cellular processes integral to cell growth, survival, and development, and its deregulation leads to cancer (Nesbit et al., 1999) . Conversely, increased PML protein levels inhibit proliferation (Koken et al., 1995; Liu et al., 1995) , mainly through gene expression control by sequestering and modulating the post-translational status of several transcription factors (Salomoni and Pandolfi, 2002) . It was recently suggested that PML is involved in the surveillance of c-Myc activity participating in c-Myc post-translational modifications (Cairo et al., 2005) . In addition, PML and c-Myc may be involved in apoptosis through the regulation of p27(kip1). The latter is a target of transcriptional repression by c-Myc (Yang et al., 2001) and is recruited by PML along with other apoptotic factors to nuclear bodies (Quignon et al., 1998) . Interestingly, the acute promyelocytic leukaemia (APL) PML/RAR alpha oncoprotein delocalizes them from these bodies (Quignon et al., 1998) . PML is a direct gene regulated by IRF-8 in activated macrophages, and IRF-8 −/− mice are defective in induced expression of PML in activated macrophages that is accompanied by lack of nuclear bodies (Dror et al., unpublished data) . Interestingly, three of the target genes identified, i.e. MAP4K4, IL-17R, and SOCS7 are involved in different stages of the NFB signaling pathway that eventually leads to the transcriptional regulation of a wide array of pro-inflammatory genes in macrophages (Karin and Greten, 2005) (Fig. 4) . Therefore, our results suggest an important role for IRF-1 and IRF-8 in the tight control of this pathway. Furthermore, an interesting aspect of this regulatory network may be the link between IRFs, SOCS7, and LIF (Fig. 4) . Following treatment with IFN-␥ and LPS the induced expression of IRF-1 and IRF-8 is regulated by STAT-1. Subsequently, the induced IRF-1 and IRF-8 regulate the expression of SOCS7 and in addition, IRF-8 regulates the expression of LIF. LIF has potent pro-inflammatory properties, being the inducer of the acute phase protein synthesis and affecting the cell recruitment into the area of damage or inflammation (Verfaillie and McGlave, 1991; Chodorowska et al., 2004) . LIF also regulates the expression of SOCS1 (and possibly of SOCS7 as well) leading to the downregulation loop of SATA1 signaling.
Taken together, we propose a pivotal role for IRF-1 and IRF-8 in regulating the expression levels of genes that participate in significant biological processes during macrophage activation while functioning as part of the innate immune response.
At this stage of our research, the exact nature of the regulatory role of both IRF-1 and IRF-8 on these identified genes is still elusive. One possible scenario is that both proteins regulate these target genes in concert, either directly through the association to the promoters of these genes, or indirectly, via regulating other transcription elements that eventually lead to the regulation of these genes. Collectively, our results suggest that IRF-1 and IRF-8 are key elements in major processes taking place during macrophage activation and are crucial to the macrophage functioning in inflammation.
